Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)

SHA:600976 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 3, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Jan 1, 2021
Market Capitalization	5,226	6,394	9,916	7,551	11,989	3,895
Market Cap Growth	-17.75%	-35.52%	31.31%	-37.01%	207.81%	42.88%
Enterprise Value	4,240	5,531	9,131	6,672	11,258	3,392
Last Close Price	34.07	40.80	62.52	46.90	73.07	23.31
PE Ratio	15.80	17.65	19.02	18.50	39.27	26.35
Forward PE	-	15.25	15.25	15.25	15.25	15.25
PS Ratio	1.65	1.82	2.35	2.07	3.63	1.59
PB Ratio	2.01	2.61	4.39	4.05	8.06	2.94
P/TBV Ratio	2.04	2.66	4.47	4.13	8.28	3.01
P/FCF Ratio	32.57	56.10	48.63	51.06	62.52	48.71
P/OCF Ratio	19.54	27.29	36.95	34.98	48.36	31.03
EV/Sales Ratio	1.34	1.58	2.17	1.83	3.41	1.38
EV/EBITDA Ratio	24.33	38.10	26.38	22.62	47.72	45.60
EV/EBIT Ratio	31.67	49.56	29.16	25.39	54.27	63.18
EV/FCF Ratio	26.43	48.53	44.78	45.11	58.71	42.42
Debt / Equity Ratio	0.05	0.07	0.05	0.03	0.05	0.02
Debt / EBITDA Ratio	0.68	1.16	0.32	0.18	0.30	0.27
Debt / FCF Ratio	0.74	1.54	0.56	0.36	0.37	0.25
Asset Turnover	0.74	0.83	1.11	1.16	1.25	1.13
Inventory Turnover	3.88	4.56	5.60	7.06	8.34	8.03
Quick Ratio	1.34	1.20	1.18	1.16	1.17	1.10
Current Ratio	1.59	1.49	1.49	1.50	1.41	1.42
Return on Equity (ROE)	13.25%	15.63%	25.39%	24.22%	21.77%	11.75%
Return on Assets (ROA)	1.96%	1.65%	5.14%	5.22%	4.92%	1.54%
Return on Invested Capital (ROIC)	7.95%	7.26%	23.62%	27.42%	25.02%	6.67%
Return on Capital Employed (ROCE)	4.90%	4.40%	13.50%	13.80%	13.50%	4.00%
Earnings Yield	6.24%	5.67%	5.26%	5.40%	2.55%	3.79%
FCF Yield	3.07%	1.78%	2.06%	1.96%	1.60%	2.05%
Dividend Yield	2.64%	2.21%	1.92%	2.13%	1.10%	1.57%
Payout Ratio	43.24%	51.83%	29.95%	30.39%	19.20%	21.07%
Buyback Yield / Dilution	1.31%	0.49%	-0.43%	-0.26%	1.35%	-0.96%
Total Shareholder Return	3.97%	2.69%	1.49%	1.87%	2.45%	0.61%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.